Curcumin reverses doxorubicin resistance in colon cancer cells at the metabolic level
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Curcumin reverses doxorubicin resistance in colon cancer cells at the metabolic level
Authors
Keywords
Curcumin, Colon cancer, Biosynthesis of polyamines, P-glycoprotein, Metabolomics, D-glutamine metabolism
Journal
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
Volume 201, Issue -, Pages 114129
Publisher
Elsevier BV
Online
2021-05-08
DOI
10.1016/j.jpba.2021.114129
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic targeting of glutaminolysis as an essential strategy to combat cancer
- (2019) José M. Matés et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- MicroRNA-128-3p aggravates doxorubicin-induced liver injury by promoting oxidative stress via targeting Sirtuin-1
- (2019) Xuerong Zhao et al. PHARMACOLOGICAL RESEARCH
- Beneficial effects of Oridonin on myocardial ischemia/reperfusion injury: Insight gained by metabolomic approaches
- (2019) Junhong Zhang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Glutamine Anabolism Plays a Critical Role in Pancreatic Cancer by Coupling Carbon and Nitrogen Metabolism
- (2019) Alex J. Bott et al. Cell Reports
- Curcumin inhibits the expression of ornithine decarboxylase and adenosine deaminase genes in MCF-7 human breast cancer cells
- (2018) Hossein Abbaspour et al. Archives of Biological Sciences
- Potential Health Benefits of Olive Oil and Plant Polyphenols
- (2018) Monika Gorzynik-Debicka et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Ginnalin A from Kujin tea (Acer tataricum subsp. ginnala) exhibits a colorectal cancer chemoprevention effect via activation of the Nrf2/HO-1 signaling pathway
- (2018) Wu Bi et al. Food & Function
- Curcumin as a functional food-derived factor: degradation products, metabolites, bioactivity, and future perspectives
- (2018) Takanori Tsuda Food & Function
- CD155 downregulation synergizes with adriamycin to induce breast cancer cell apoptosis
- (2018) Jian Gao et al. APOPTOSIS
- Curcumin Reverses 5-Fluorouracil Resistance by Promoting Human Colon Cancer HCT-8/5-FU Cell Apoptosis and Down-regulating Heat Shock Protein 27 and P-Glycoprotein
- (2018) Wen-ting He et al. Chinese Journal of Integrative Medicine
- Preclinical studies for the combination of paclitaxel and curcumin in cancer therapy
- (2017) Yumeng Wei et al. ONCOLOGY REPORTS
- Effect of traditional Chinese medicine components on multidrug resistance in tumors mediated by P-glycoprotein
- (2017) Xi Xia et al. Oncology Letters
- Anti-tumor bioactivities of curcumin on mice loaded with gastric carcinoma
- (2017) Xiao-Ping Wang et al. Food & Function
- Multi-omics analysis reveals that ornithine decarboxylase contributes to erlotinib resistance in pancreatic cancer cells
- (2017) Won-Jun Jang et al. Oncotarget
- Novel strategies to prevent the development of multidrug resistance (MDR) in cancer
- (2017) Jinglu Wang et al. Oncotarget
- Investigations on the cell metabolomics basis of multidrug resistance from tumor cells by ultra-performance liquid chromatography–mass spectrometry
- (2016) Ruixing Zhang et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Targeting polyamine metabolism for cancer therapy and prevention
- (2016) T. R. Murray-Stewart et al. BIOCHEMICAL JOURNAL
- ABC transporters as mediators of drug resistance and contributors to cancer cell biology
- (2016) Jamie I. Fletcher et al. DRUG RESISTANCE UPDATES
- Curcumin: A new candidate for melanoma therapy?
- (2016) Hamed Mirzaei et al. INTERNATIONAL JOURNAL OF CANCER
- Increasing role of the cancer chemotherapeutic doxorubicin in cellular metabolism
- (2016) Ann-Marie Meredith et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Redox Control of Multidrug Resistance and Its Possible Modulation by Antioxidants
- (2016) Aysegul Cort et al. Oxidative Medicine and Cellular Longevity
- Evaluation of the efficacy of paclitaxel with curcumin combination in ovarian cancer cells
- (2016) Zeng Liu et al. Oncology Letters
- Targeting ABCB1 (MDR1) in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance
- (2016) Tang Liu et al. Oncotarget
- Natural Product Modulators to Overcome Multidrug Resistance In Cancer
- (2015) Aysegul Cort et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- 1H nuclear magnetic resonance-based extracellular metabolomic analysis of multidrug resistant Tca8113 oral squamous carcinoma cells
- (2015) HUI WANG et al. Oncology Letters
- P-glycoprotein is expressed and causes resistance to chemotherapy in EBV-positive T-cell lymphoproliferative diseases
- (2015) Mayumi Yoshimori et al. Cancer Medicine
- Metabolomic approach to evaluating adriamycin pharmacodynamics and resistance in breast cancer cells
- (2013) Bei Cao et al. Metabolomics
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started